Results 121 to 130 of about 7,354,999 (259)

Serum Immunologic Markers for Monitoring Allergen-Specific Immunotherapy

open access: yes, 2011
Allergen immunotherapy is an effective treatment option in patients with IgE-mediated allergy, particularly in those who do not respond to usual antiallergic drugs.
Shamji, Mohamed H.   +3 more
core   +1 more source

As‐Needed Versus Regular Medication Use in the Treatment of Allergic Rhinitis in the Pollen Season: A MASK‐air Study

open access: yesAllergy, EarlyView.
Using MASK‐air app data from 1042 users across 2690 weeks, this study compared the impact of regular versus as‐needed allergic rhinitis medication on symptom control and treatment satisfaction. Mixed‐effects linear regression models and sensitivity analyses revealed no significant differences between the two approaches, with results for oral ...
Bernardo Sousa‐Pinto   +38 more
wiley   +1 more source

Allergen-specific immunotherapy: State of the art

open access: yesGlobal Pediatrics
Allergen-specific immunotherapy (AIT) was born in 1911 and great progress has been made over the last 110 years, from the invention of subcutaneous and sublingual administration to new strategies.
Roberto Bernardini   +3 more
doaj   +1 more source

Mechanisms of allergen-specific immunotherapy

open access: yes, 2018
Objective The aim of this review is to provide an overview of the current knowledge on the mechanisms of allergen immunotherapy based on the recent publications and clinical trials. Data sources PubMed literature review.
Satitsuksanoa, Pattraporn   +6 more
core   +1 more source

Understanding the Type 2 Immunity: An Evolving View Beyond Allergic Diseases

open access: yesAllergy, EarlyView.
ABSTRACT Type 2 (T2) immunity is classically associated with defense against helminths and environmental threats, from a physiological perspective, and with allergies and eosinophilic inflammatory diseases, in a pathological sense. However, growing evidence reveals that T2 pathways also support other essential homeostatic functions, including tissue ...
Rodrigo Jiménez‐Saiz   +22 more
wiley   +1 more source

Safety and Clinical Outcomes of High‐ Versus Low‐Dose Oral Peanut Immunotherapy in Polish Children With Peanut Allergy

open access: yesActa Paediatrica, EarlyView.
ABSTRACT Aim To compare safety and clinical outcomes of two different oral immunotherapy (OIT) maintenance doses (150 mg vs. 300 mg) of peanut protein in children with peanut allergy. Methods This prospective study enrolled 44 children aged 4–17 years with confirmed peanut allergy.
Klementyna Łyżwa   +4 more
wiley   +1 more source

Adherence to Treatment in Allergic Rhinitis During the Pollen Season in Europe: A MASK‐air Study

open access: yesClinical &Experimental Allergy, Volume 55, Issue 3, Page 226-238, March 2025.
In a study assessing mobile health data, (i) adherence to rhinitis medication was highest for oral antihistamines and lowest for azelastine‐fluticasone, (ii) in weeks of partial adherence, azelastine‐fluticasone was associated with lower levels of reported rhinitis symptoms than other medication classes.
Bernardo Sousa‐Pinto   +121 more
wiley   +1 more source

Requirements for acquiring a high-quality house dust mite extract for allergen immunotherapy

open access: yesDrug Design, Development and Therapy, 2012
Franco Frati,1 Cristoforo Incorvaia,2 Marie David,3 Silvia Scurati,3 Simona Seta,4 Guglielmo Padua,4 Eleonora Cattaneo,1 Carlo Cavaliere,5 Alessia Di Rienzo,6 Ilaria Dell'Albani,1 Paola Puccinelli11Medical and Scientific and Regulatory Department,
Frati F   +10 more
doaj  

Immunoglobulin G in IgE-mediated allergy and allergen-specific immunotherapy

open access: yes, 2014
Allergen-specific IgG antibodies play a significant role in allergen-specific tolerance, either naturally induced or generated by specific immunotherapy.
Hofmaier S, Comberiati P, Matricardi PM.
core  

Expanding the Utility of Gold Nanocluster “Allergolds” to Peanut Allergen Ara h 2

open access: yes
Allergy, EarlyView.
Gage O. Leighton   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy